These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32911244)

  • 1. Long-term trends in tobacco use assessed by wastewater-based epidemiology and its relationship with consumption of nicotine containing products.
    Zheng Q; Gartner C; Tscharke BJ; O'Brien JW; Gao J; Ahmed F; Thomas KV; Mueller JF; Thai PK
    Environ Int; 2020 Dec; 145():106088. PubMed ID: 32911244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of anabasine, anatabine, and nicotine biomarkers in wastewater by enhanced direct injection LC-MS/MS and evaluation of their in-sewer stability.
    Zheng Q; Eaglesham G; Tscharke BJ; O'Brien JW; Li J; Thompson J; Shimko KM; Reeks T; Gerber C; Thomas KV; Thai PK
    Sci Total Environ; 2020 Nov; 743():140551. PubMed ID: 32653706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabasine-based measurement of cigarette consumption using wastewater analysis.
    Bade R; White JM; Tscharke BJ; Ghetia M; Abdelaziz A; Gerber C
    Drug Test Anal; 2020 Sep; 12(9):1393-1398. PubMed ID: 32506745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of tobacco use by wastewater analysis of anabasine and anatabine.
    Tscharke BJ; White JM; Gerber JP
    Drug Test Anal; 2016 Jul; 8(7):702-7. PubMed ID: 26198173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring spatial and temporal trends of nicotine and alcohol consumption in Australia using wastewater-based epidemiology.
    Lai FY; Gartner C; Hall W; Carter S; O'Brien J; Tscharke BJ; Been F; Gerber C; White J; Thai P; Bruno R; Prichard J; Kirkbride KP; Mueller JF
    Addiction; 2018 Jun; 113(6):1127-1136. PubMed ID: 29333692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anabasine and Anatabine Exposure Attributable to Cigarette Smoking: National Health and Nutrition Examination Survey (NHANES) 2013-2014.
    Bendik PB; Rutt SM; Pine BN; Sosnoff CS; Blount BC; Zhu W; Feng J; Wang L
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35955098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in nicotine consumption between 2010 and 2017 in an Australian city using the wastewater-based epidemiology approach.
    Mackie RS; Tscharke BJ; O'Brien JW; Choi PM; Gartner CE; Thomas KV; Mueller JF
    Environ Int; 2019 Apr; 125():184-190. PubMed ID: 30716578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy.
    Jacob P; Hatsukami D; Severson H; Hall S; Yu L; Benowitz NL
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1668-73. PubMed ID: 12496059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a LC-MS/MS method for quantifying urinary nicotine, six nicotine metabolites and the minor tobacco alkaloids--anatabine and anabasine--in smokers' urine.
    McGuffey JE; Wei B; Bernert JT; Morrow JC; Xia B; Wang L; Blount BC
    PLoS One; 2014; 9(7):e101816. PubMed ID: 25013964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues.
    Marclay F; Grata E; Perrenoud L; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):73-84. PubMed ID: 21719221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of the Minor Tobacco Alkaloids Nornicotine, Anatabine, and Anabasine in Smokers' Urine by High Throughput Liquid Chromatography-Mass Spectrometry.
    von Weymarn LB; Thomson NM; Donny EC; Hatsukami DK; Murphy SE
    Chem Res Toxicol; 2016 Mar; 29(3):390-7. PubMed ID: 26825008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in raw wastewater as an innovative perspective for investigating population-wide exposure to third-hand smoke.
    Lai FY; Lympousi K; Been F; Benaglia L; Udrisard R; Delémont O; Esseiva P; Thomaidis NS; Covaci A; van Nuijs ALN
    Sci Rep; 2018 Sep; 8(1):13254. PubMed ID: 30185880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes.
    Jacob P; Yu L; Shulgin AT; Benowitz NL
    Am J Public Health; 1999 May; 89(5):731-6. PubMed ID: 10224986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach for monitoring tobacco use in local communities by wastewater analysis.
    Castiglioni S; Senta I; Borsotti A; Davoli E; Zuccato E
    Tob Control; 2015 Jan; 24(1):38-42. PubMed ID: 25015371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring caffeine and nicotine use in a nationwide study in Italy using wastewater-based epidemiology.
    Gracia-Lor E; Rousis NI; Zuccato E; Castiglioni S
    Sci Total Environ; 2020 Dec; 747():141331. PubMed ID: 32799024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography-tandem mass spectrometry.
    Xu X; Iba MM; Weisel CP
    Clin Chem; 2004 Dec; 50(12):2323-30. PubMed ID: 15472033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic effects of tobacco smoke constituents in nonhuman primates.
    Desai RI; Doyle MR; Withey SL; Bergman J
    Psychopharmacology (Berl); 2016 May; 233(10):1779-89. PubMed ID: 26892379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First nation-wide estimation of tobacco consumption in Spain using wastewater-based epidemiology.
    Montes R; Rodil R; Rico A; Cela R; González-Mariño I; Hernández F; Bijlsma L; Celma A; Picó Y; Andreu V; de Alda ML; López-García E; Postigo C; Pocurull E; Marcé RM; Rosende M; Olivares M; Valcárcel Y; Quintana JB
    Sci Total Environ; 2020 Nov; 741():140384. PubMed ID: 32603944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference interval determination for anabasine: a biomarker of active tobacco use.
    Suh-Lailam BB; Haglock-Adler CJ; Carlisle HJ; Ohman T; McMillin GA
    J Anal Toxicol; 2014 Sep; 38(7):416-20. PubMed ID: 24939383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles.
    Moyer TP; Charlson JR; Enger RJ; Dale LC; Ebbert JO; Schroeder DR; Hurt RD
    Clin Chem; 2002 Sep; 48(9):1460-71. PubMed ID: 12194923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.